1.TRPA1 Antagonists for Pain Relief , Pharmaceuticals 2018, 11(4), 117;https://doi.org/10.3390/ph11040117 2.Is TRPA1 Burning Down TRPV1 as Druggable Target for the Treatment of Chronic Pain? Int J Mol Sci. 2019 Jun; 20(12): 2906. 3.TRPA1 as a drug target—promise and challenges ...
[2] Bender MJ, McPherson AC, Phelps CM, et al. Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell. 2023 Apr 27;186(9):1846-1862. [3] Zhang Q, Zhao Q, Li T, et al. Lactobacillus plantarum-derived indole-3-lacti...
3. J.M. Hyser, M.K. Estes, Pathophysiological consequences of calcium-conducting viroporins, Annu. Rev. Virol. 2 (2015) 473–496. 4. Jaffal SM, Abbas MA. TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem Biol Interact. 2021 Aug 25;345:109567. do...
The update of TRPV1 in the pathogenesis and treatment of atopic dermatitis is reviewed in this paper. Key words: atopic dermatitis, transient receptor potential family, TRPV1, pathogenesis, treatment 引用本文 燕红霞, 花日, 贾秀娟, 王百灵, 高志清, 张小峰, 吴凤兰, 木其日. TRPV1在特应...
20. Kempkes C, Buddenkotte J, Cevikbas F, Buhl T, Steinhoff M. Role of PAR-2 in Neuroimmune Communication and Itch In: Carstens E, Akiyama T, editors. Itch: Mechanisms and Treatment. Frontiers in Neuroscience; Boca Raton (FL); 2014...
4. Jaffal SM, Abbas MA. TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem Biol Interact. 2021 Aug 25;345:109567. doi: 10.1016/j.cbi.2021.109567. 5. J. Yang, C. Chen, W. Chen, L. Huang, Z. Fu, K. Ye, L. Lv, Z. Nong, X. Zhou, W. ...
2. Nygaard U, Deleuran M, Vestergaard C. Emerging treatment options in atopic dermatitis: topical therapies. Dermatology 2017; 233: 333– 43. 3. Paller AS, Kabashima K, Bieber T. Therapeutic pipeline for atopic dermatitis: end of the dro...
The compounds of formula (I) are useful as antagonists of TRPM8. Such compounds are useful in treating numerous disorders or conditions in which TRPM8-mediated, may be used such disorders or conditions for preparing a medicament useful and pharmaceutical compositions for treating . Examples of ...
Treatment with these drugs has been shown to improve the prognosis in patients with heart failure with reduced systolic function, but the mortality for heart failure still remains unacceptably high. Thus, additional approaches are greatly required as the prevalence of cardiovascular diseases continues to...
4. Jaffal SM, Abbas MA. TRP channels in COVID-19 disease: Potential targets for prevention and treatment. Chem Biol Interact. 2021 Aug 25;345:109567. doi: 10.1016/j.cbi.2021.109567. 5. J. Yang, C. Chen, W. Chen, L. Huang, Z. Fu, K. Ye, L. Lv, Z. Nong, X. Zhou, W. ...